Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden
- PMID: 4020124
- DOI: 10.1097/00004872-198504000-00010
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden
Abstract
Prognostic factors for cardiovascular disease (CVD) were studied in treated, middle-aged male hypertensives, derived from a random population sample and followed for more than 10 years. In multivariate analysis diastolic blood pressure, smoking, serum cholesterol, proteinuria, angina pectoris and previous stroke were found to be independent predictors of CVD morbidity (non-fatal myocardial infarction (MI), non-fatal stroke, or CVD death). Multivariate analyses for coronary heart disease (CHD), stroke and CVD mortality were also performed and the results are given. Life-table analyses showed a three times higher CVD incidence among smokers than amongst non-smokers and a doubled incidence for subjects with a serum cholesterol in the highest quartile, i.e. above 7.3 mmol/l, compared with those with levels below, and a three times higher incidence for subjects with proteinuria than those without. Non-smokers with a serum cholesterol below 7.3 mmol/l and free of any hypertensive organ manifestation at entry did not differ significantly in CVD morbidity from a normotensive comparison group that was derived from the same population sample. These findings in a well-defined population sample show that in spite of treatment for hypertension the CVD risk is still substantial if organ damage or other risk factors are present. These findings underline the importance of multiple risk intervention.
Similar articles
-
Prognostic factors in treated hypertension.J Hypertens Suppl. 1985 Dec;3(3):S497-500. J Hypertens Suppl. 1985. PMID: 2856777
-
Mortality and morbidity in relation to systolic blood pressure in two populations with different management of hypertension: The Study of Men Born in 1913 and the Multifactorial Primary Prevention Trial.J Hypertens. 1987 Feb;5(1):57-66. doi: 10.1097/00004872-198702000-00009. J Hypertens. 1987. PMID: 3584964
-
Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.Acta Med Scand Suppl. 1985;702:1-79. Acta Med Scand Suppl. 1985. PMID: 3866485
-
Experiences from hypertension trials. Impact of other risk factors.Drugs. 1988;36 Suppl 3:9-20. doi: 10.2165/00003495-198800363-00005. Drugs. 1988. PMID: 3076127 Review.
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
Cited by
-
Reduction in basal nitric oxide activity causes albuminuria.Diabetes. 2011 Feb;60(2):572-6. doi: 10.2337/db09-1630. Diabetes. 2011. PMID: 21270268 Free PMC article. Clinical Trial.
-
Experiences from hypertension trials--effects on stroke and coronary heart disease.Drugs. 1988;36 Suppl 3:5-8. doi: 10.2165/00003495-198800363-00004. Drugs. 1988. PMID: 3076121 Review.
-
Proteinuria as a prognostic factor during long term hypertensive care.Drugs. 1988;35 Suppl 5:48-54. doi: 10.2165/00003495-198800355-00008. Drugs. 1988. PMID: 3063485 Review.
-
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.BMC Nephrol. 2013 Apr 25;14:95. doi: 10.1186/1471-2369-14-95. BMC Nephrol. 2013. PMID: 23617441 Free PMC article.
-
'Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model'.J Diabetes Metab Disord. 2023 May 22;22(2):1095-1103. doi: 10.1007/s40200-023-01186-5. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical